T. A. W. Splinter

1.1k total citations
39 papers, 909 citations indexed

About

T. A. W. Splinter is a scholar working on Oncology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, T. A. W. Splinter has authored 39 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Epidemiology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in T. A. W. Splinter's work include Neuroendocrine Tumor Research Advances (15 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Treatments and Mutations (6 papers). T. A. W. Splinter is often cited by papers focused on Neuroendocrine Tumor Research Advances (15 papers), Lung Cancer Research Studies (14 papers) and Lung Cancer Treatments and Mutations (6 papers). T. A. W. Splinter collaborates with scholars based in Netherlands, Belgium and United Kingdom. T. A. W. Splinter's co-authors include Ate van der Gaast, T.C. Kok, Dorothy A. Brown, E H Cooper, Michael Peake, M F Muers, Freddy Cornillie, N. Duez, Harry Bleiberg and G. Stoter and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Cancer.

In The Last Decade

T. A. W. Splinter

38 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
T. A. W. Splinter Netherlands	17	476	324	301	236	188	39	909
William H. Isacoff United States	16	499 1.0×	223 0.7×	227 0.8×	138 0.6×	152 0.8×	25	804
Seung Yeon Ha South Korea	17	300 0.6×	212 0.7×	193 0.6×	289 1.2×	143 0.8×	82	859
S Yamasaki Japan	16	603 1.3×	351 1.1×	841 2.8×	529 2.2×	107 0.6×	30	1.8k
Manabu Yamamoto Japan	18	275 0.6×	562 1.7×	429 1.4×	147 0.6×	250 1.3×	61	1.1k
Saburo Fukuda Japan	15	216 0.5×	198 0.6×	405 1.3×	186 0.8×	114 0.6×	57	765
Claude Merrin United States	20	264 0.6×	491 1.5×	612 2.0×	84 0.4×	144 0.8×	56	1.1k
Andrea Gardini Italy	19	440 0.9×	283 0.9×	538 1.8×	386 1.6×	180 1.0×	40	1.3k
Monica Di Battista Italy	17	222 0.5×	424 1.3×	238 0.8×	73 0.3×	189 1.0×	40	810
Makoto Toi Japan	17	190 0.4×	227 0.7×	194 0.6×	111 0.5×	340 1.8×	65	800

Countries citing papers authored by T. A. W. Splinter

Since Specialization

Citations

This map shows the geographic impact of T. A. W. Splinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. A. W. Splinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. A. W. Splinter more than expected).

Fields of papers citing papers by T. A. W. Splinter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. A. W. Splinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. A. W. Splinter. The network helps show where T. A. W. Splinter may publish in the future.

Co-authorship network of co-authors of T. A. W. Splinter

This figure shows the co-authorship network connecting the top 25 collaborators of T. A. W. Splinter. A scholar is included among the top collaborators of T. A. W. Splinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. A. W. Splinter. T. A. W. Splinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Polée, M., et al.. (2001). Phase II study of the combination cisplatin, etoposide, 5-fluorouracil and folinic acid in patients with advanced squamous cell carcinoma of the esophagus. Anti-Cancer Drugs. 12(6). 513–517. 34 indexed citations

Duffaud, Florence, M Namer, W ten Bokkel Huinink, et al.. (2001). D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study. Anti-Cancer Drugs. 12(2). 159–162. 21 indexed citations

Salden, Martin, et al.. (2000). The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Annals of Oncology. 11(3). 327–332. 46 indexed citations

Splinter, T. A. W.. (1997). Introduction to the treatment of lung cancer.. PubMed. 24(4 Suppl 12). S12–1. 6 indexed citations

Østerlind, Kell, et al.. (1996). Serum neuron-specific enolase (S-NSE) and the prognosis in small-cell lung cancer (SCLC): a combined multivariable analysis on data from nine centres. British Journal of Cancer. 74(3). 463–467. 76 indexed citations

Neijt, J.P., et al.. (1995). Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative Group. British Journal of Cancer. 71(1). 106–108. 18 indexed citations

Conroy, Thierry, P Cappelaere, Michel Fabbro, et al.. (1994). Acute Antiemetic Efficacy and Safety of Dolasetron Mesylate, A 5-HT3 Antagonist, in Cancer Patients Treated with Cisplatin. American Journal of Clinical Oncology. 17(2). 97–102. 36 indexed citations

Gaast, Ate van der, M. Bontenbal, A.S.T. Planting, T.C. Kok, & T. A. W. Splinter. (1994). Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer. Annals of Oncology. 5(9). 858–860. 6 indexed citations

Splinter, T. A. W., et al.. (1994). Acute myeloid leukaemia with +i(12p) shortly after treatment of mediastinal germ cell tumour. British Journal of Haematology. 88(1). 196–198. 16 indexed citations

10.

Gaast, Ate van der, et al.. (1994). Evaluation of a new tumour marker in patients with non-small-cell lung cancer: Cyfra 21.1. British Journal of Cancer. 69(3). 525–528. 98 indexed citations

11.

Postmus, Pieter E., et al.. (1993). Long term survival of small cell lung cancer patients after chemotherapy. British Journal of Cancer. 67(4). 822–824. 16 indexed citations

12.

Planting, A.S.T., T. A. W. Splinter, Andrea Ardizzoni, et al.. (1992). Phase II study of ACNU as second-line treatment in small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 29(5). 409–411. 7 indexed citations

13.

Planting, A.S.T., Andrea Ardizzoni, Giuseppe Giaccone, et al.. (1991). Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872. Cancer Chemotherapy and Pharmacology. 28(2). 145–146. 5 indexed citations

14.

Mulder, Marlies, W. Keijzer, T. A. W. Splinter, & Johannes L. Bos. (1991). Frequent Occurrence of Activated ras Oncogenes in Seminomas but Not in Nonseminomatous Germ Cell Tumors. Recent results in cancer research. 123. 125–131. 4 indexed citations

15.

Gaast, Ate van der, T.C. Kok, & T. A. W. Splinter. (1991). Growing Teratoma Syndrome Successfully Treated with Lymphoblastoid Interferon. European Urology. 19(3). 257–258. 18 indexed citations

16.

Splinter, T. A. W., H. Obertop, T.C. Kok, & Johannes Jeekel. (1989). Adjuvant chemotherapy after resection of adenocarcinoma of the periampullary region and the head of the pancreas. Journal of Cancer Research and Clinical Oncology. 115(2). 200–202. 39 indexed citations

17.

Splinter, T. A. W., et al.. (1989). Mitoxantrone, methotrexate, and 5-fluorouracil (MMF) in hormone-refractory advanced breast cancer.. PubMed. 35(5-6). 225–31. 2 indexed citations

18.

Janssen, J. A. M. J. L., P. J. Blankestijn, R. Docter, et al.. (1989). Effects of immunoscintigraphy with monoclonal antibodies in assays of hormones and tumour markers.. BMJ. 298(6686). 1511–1513. 12 indexed citations

19.

Splinter, T. A. W., et al.. (1988). Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 114(6). 641–643. 4 indexed citations

20.

Stoter, G., T. A. W. Splinter, J. Anthony Child, et al.. (1987). Combination Chemotherapy with Cisplatin and Methotrexate in Advanced Transitional Cell Cancer of the Bladder. The Journal of Urology. 137(4). 663–667. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact